![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Highly regulated manufacturing operations must control access to devices, applications and physical spaces to ensure data integrity, compliance and security without compromising productivity. Nymi is bringing a new innovative authentication solution to these operations with the Nymi Enterprise Edition.
Nymi Enterprise Edition authentication is a comprehensive solution consisting of a multi-factor biometrically authenticated wearable (the Nymi Band) and a complete enterprise system for administration, management and integration into existing identity ecosystems. It provides the industry’s first enterprise-grade authentication solution that addresses data integrity and compliance concerns.
Unlike security measures that rely on passwords, PINs or tokens – all of which can be lost, shared or stolen – the Nymi Band features both fingerprint and ECG sensors to ensure the user authenticating is indeed the correct person. The on-body detection adds another layer of assurance for accomplishing non-repudiation of actions in highly regulated manufacturing processes.
Nymi Enterprise Edition integrates with existing Identity Access Management (IAM) solutions and Manufacturing Execution Systems (MES) to accomplish digital signatures and store electronic batch records. With easier, more secure and efficient non-repudiation mechanisms, Nymi Enterprise Edition enables users to significantly reduce deviations and compliance costs related to 21 CFR Part 11.
“Nymi solves the most critical problems around data integrity, compliance and user non-repudiation driving the shift toward Industry 4.0,” said Dave Rai, chief operating officer, Nymi. “By moving to an ‘on-body, always on” authentication model, users of the Nymi Enterprise Edition realize significant improvements in data integrity, security and productivity. With the Nymi Enterprise Edition, deployment is quick and easy as the architecture leverages the existing MES and IAM infrastructure.”
To further ease integration, Nymi has partnered with leading life sciences providers,including Werum and Evidian.This partnership is helping provide seamless integration with Werum’s PAS-X MES and Evidian’s E-SSOflexible Single-Sign On solution.
“We are impressed by this great new idea of biometric user authentication and believe that it is a perfect addition to our PAS-X MES application. Not only will it help strengthen our customer’s data integrity, but it will also help address compliance requirements in pharma production,“ said Florian Grabow, senior head of account and program management, Werum.
“Nymi is an innovative authentication solution selected by Evidian since its creation for its very high level of simplicity for the user and security for the enterprise. Nymi Enterprise Edition provides companies with a multi-factor authentication solution that is both highly secure and easy-to-use,” said Sébastien Brachet, chief operating officer, Evidian. “Nymi Enterprise Edition will allow our clients operating in highly regulated environments, such as laboratories, to continuously improve their user experience and satisfaction.”
About Nymi
Nymi Inc is an enterprise authentication solutions company whose mission is to deliver effortless, continuous authentication anywhere. Nymi’s enterprise authentication solutions dramatically improve data integrity and reduce compliance costs. Data integrity is critical to all enterprises, but especially for the regulated, compliance-driven industries such as pharmaceuticals. Nymi solutions are highly secure, easy to deploy, and result in improved productivity all with uncompromising data integrity.
Headquartered in Toronto, Canada, Nymi is privately owned with backing from top-tier financial and strategic investors. For more information, please visit nymi.com.
